| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | 
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Total Revenue | 40.50B | 40.91B | 39.37B | 37.77B | 31.09B | 23.97B | 
| Gross Profit | 17.37B | 17.73B | 16.74B | 14.83B | 12.26B | 9.88B | 
| EBITDA | 6.32B | 6.42B | 6.67B | 5.52B | 4.54B | 3.64B | 
| Net Income | 4.06B | 4.29B | 4.27B | 3.35B | 2.90B | 2.08B | 
| Balance Sheet | ||||||
| Total Assets | 0.00 | 29.03B | 29.04B | 27.41B | 25.92B | 25.30B | 
| Cash, Cash Equivalents and Short-Term Investments | 2.88B | 2.87B | 5.14B | 5.53B | 4.47B | 7.19B | 
| Total Debt | 0.00 | 621.00M | 604.00M | 697.00M | 705.00M | 639.00M | 
| Total Liabilities | -13.30B | 15.73B | 15.74B | 14.24B | 13.32B | 12.42B | 
| Stockholders Equity | 13.30B | 13.30B | 13.30B | 13.16B | 12.60B | 12.88B | 
| Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.04B | 3.67B | 3.82B | 580.00M | 2.55B | 
| Operating Cash Flow | 0.00 | 3.11B | 4.86B | 4.86B | 1.21B | 2.83B | 
| Investing Cash Flow | 0.00 | 1.23B | -860.00M | -151.00M | 2.30B | -2.25B | 
| Financing Cash Flow | 0.00 | -4.59B | -4.39B | -3.02B | -3.46B | -1.74B | 
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth | 
|---|---|---|---|---|---|---|---|
| ― | ₹205.16B | 18.06 | ― | 1.00% | 0.95% | 67.04% | |
| ― | ₹168.91B | 21.94 | ― | 0.36% | -2.12% | -22.09% | |
| ― | ₹152.63B | 38.09 | ― | 2.72% | 1.28% | -5.89% | |
| ― | ₹27.05B | 50.98 | ― | 0.29% | 29.03% | -17.42% | |
| ― | ₹49.09B | 34.67 | ― | 0.34% | 0.75% | -0.74% | |
| ― | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | 
Akzo Nobel India Limited has announced a pre-offer advertisement and corrigendum to a detailed public statement for its shareholders. This announcement is part of regulatory compliance under SEBI’s SAST Regulations, indicating ongoing corporate actions that may impact shareholder interests and company operations.
Akzo Nobel India Limited has announced the recommendation of its Committee of Independent Directors (IDC) regarding an open offer made by JSW Paints Limited and its partners. The offer involves the acquisition of a significant portion of Akzo Nobel’s shares, representing 26% of the company’s voting share capital, at a substantial price per share. This move could potentially impact the company’s market positioning and shareholder value, as it represents a significant investment by JSW Paints and its partners.
Akzo Nobel India Limited announced the closure of its trading window in compliance with SEBI regulations, effective from October 1, 2025, until 48 hours after the release of its unaudited financial results for the quarter and six months ending September 30, 2025. This move is part of the company’s policy to prevent insider trading, ensuring transparency and regulatory compliance, which is crucial for maintaining investor trust and market integrity.
Akzo Nobel India Limited has received a demand order from the Service Tax Department in Mumbai related to pending litigation over Cenvat credit on service tax for Goods Transport Agency services. The demand order, which follows show cause notices from 2014, requires the company to pay a revised amount of Rs. 48,56,366, including tax, interest, and penalties. The company is currently preparing to respond to this order, which may impact its financial obligations and requires ongoing monitoring until resolution.
Akzo Nobel India Limited has released an investor presentation detailing its unaudited financial results for the quarter ending June 30, 2025. This announcement, approved by the Board of Directors, reflects the company’s ongoing commitment to transparency and provides insights into its financial performance, which could influence its market positioning and stakeholder confidence.
Akzo Nobel India Limited has received an Order-in-Appeal from the Telangana GST Department regarding a tax dispute involving a demand of ₹2.9 crores, along with interest and penalties. The company is actively responding to the appeal, which may impact its financial obligations and requires further submissions to the relevant authorities.